Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOVAZA vs LUBIPROSTONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOVAZA vs LUBIPROSTONE: Safety Overview

Metric LOVAZA LUBIPROSTONE
Total FAERS Reports 303 1,214
Deaths Reported 3 118
Death Rate 1.0% 9.7%
Hospitalizations 22 332
Average Patient Age 61.8 yrs 64.0 yrs
% Female Patients N/A 66.5%
FDA Approval Date N/A Apr 29, 2008
Manufacturer N/A Direct_Rx
Route N/A ORAL
Marketing Status N/A Prescription